Pfizer Receives $ 3.5 Billion From Coronavirus Vaccine Sales For Q1 2021, Enterprise Report Says.
In total, the company expects significant revenue from vaccine sales over the next three years..
Pfizer's Projections Based on Current Vaccine Sales and Potential Agreements with Governments.
In particular, the company sold $ 3.
5 billion worth of vaccines in the first quarter of 2021.; it also already has contracts for the supply of 1.6 billion doses of vaccines by the end of the year - their implementation will bring in $ 26 billion.
In addition, in the coming months, Pfizer expects to enter into several more contracts for the supply of vaccines for this year and 2022..
This could be facilitated by full approval of the vaccine for children aged 16 and over and in the future for children 12-15 years old..